Sana Biotechnology (SANA)
(Delayed Data from NSDQ)
$5.41 USD
-0.09 (-1.64%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $5.42 +0.01 (0.18%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.27 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | -18.52% |
ABR | 1.75 |
Earnings ESP
|
-4.27% |
---|---|
Current Year | -1.24 |
Next Year | -1.08 |
EPS (TTM) | -1.40 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.27 | -0.25 | -1.24 | -1.08 |
# of Estimates | 3 | 2 | 3 | 3 |
Most Recent Consensus | -0.30 | -0.28 | -1.28 | -1.18 |
High Estimate | -0.25 | -0.21 | -1.22 | -0.90 |
Low Estimate | -0.30 | -0.28 | -1.28 | -1.18 |
Year ago EPS | -0.41 | -0.35 | -1.63 | -1.24 |
Year over Year Growth Est. | 34.15% | 28.57% | 23.93% | 13.17% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 2 | 2 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.27 | -0.25 | -1.24 | -1.08 |
7 Days Ago | -0.27 | -0.25 | -1.18 | -1.08 |
30 Days Ago | -0.25 | -0.25 | -1.17 | -1.06 |
60 Days Ago | -0.25 | -0.25 | -1.17 | -1.06 |
90 Days Ago | -0.25 | -0.25 | -1.17 | -1.06 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.29 | -0.25 | -1.24 | -1.08 |
Zacks Consensus Estimate | -0.27 | -0.25 | -1.24 | -1.08 |
Earnings ESP | -4.27% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.32 | -0.35 | -0.41 | NA |
Estimate | -0.27 | -0.30 | -0.37 | -0.42 | NA |
Difference | -0.05 | -0.02 | 0.02 | 0.01 | -0.01 |
Surprise | -18.52% | -6.67% | 5.41% | 2.38% | -4.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more